Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder

Sultan 1. Murat State Hospital

Status: Enrolling

Conditions: Fibromyalgia Syndrome; Attention-Deficit/Hyperactivity Disorder; Disease Burden

Treatments: Other: Disease Burden

Study type: Observational

Funder types: Other

Identifiers

NCT07327775

26/11/2025-12/03

Details and patient eligibility

About

In this study, the investigators aimed to evaluate the impact of having a child diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) on parental disease burden in mothers diagnosed with Fibromyalgia Syndrome (FMS).

The study will include 50 mothers with FMS who have a child diagnosed with ADHD and 50 mothers with FMS who have children without any psychiatric disorders.

Among mothers of children followed with a diagnosis of ADHD at the Child and Adolescent Psychiatry Outpatient Clinic of Edirne Sultan 1st Murat State Hospital, the presence of widespread body pain will be assessed. Mothers reporting widespread body pain will be referred to the Pain Management Outpatient Clinic of the same hospital for further evaluation for FMS. Mothers diagnosed with FMS will be included in the study group.

The comparison group will consist of mothers with FMS who have children without any psychiatric disorders. These participants will be selected from patients diagnosed with FMS who present to the Pain Management Outpatient Clinic of Edirne Sultan 1st Murat State Hospital.

Enrollment: 100 estimated patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Inclusion Criteria for Participants with Children Diagnosed with ADHD:

• Being a female aged between 18 and 50 years
• Having one or more children aged 6-17 years diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD) according to DSM-5 diagnostic criteria
• Having a diagnosis of Fibromyalgia Syndrome (FMS according to the 2016 American College of Rheumatology [ACR] criteria)
• Being literate

Inclusion Criteria for Participants with Children Without Psychiatric Disorders:

• Being a female aged between 18 and 50 years
• Having one or more children aged 6-17 years without any psychiatric disorders
• Having a diagnosis of Fibromyalgia Syndrome (FMS) according to the 2016 American College of Rheumatology (ACR) criteria
• Being literate

Exclusion criteria

• Receiving regular pharmacological treatment for Fibromyalgia Syndrome
• Having an active psychiatric disorder or using psychiatric medication
• Having a history of infectious disease, chronic inflammatory disease, or malignancy
• Being pregnant or breastfeeding
• Having a central or peripheral nervous system disorder (e.g., cerebrovascular disease, multiple sclerosis)
• Being uncooperative during clinical evaluation
• Having comorbid conditions that may affect quality of life, including congestive heart failure, chronic kidney disease, chronic liver disease, pulmonary disease, uncontrolled diabetes mellitus, or peripheral vascular disease
• Having a diagnosis of hypothyroidism or hyperthyroidism
• Having substance use disorder or alcohol use disorder

Trial design

100 participants in 2 patient groups

Mothers have children with Attention-Deficit/Hyperactivity Disorder

Description:

Mothers with Fibromyalgia Syndrome who have children with Attention-Deficit/Hyperactivity Disorder

Treatment:

Other: Disease Burden

Mothershave children without psychiatric disorders

Description:

Mothers with Fibromyalgia Syndrome who have children without psychiatric disorders

Treatment:

Other: Disease Burden